NCT04280510 Pathogenic Study of Adult Immune Enteropathies
| NCT ID | NCT04280510 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut National de la Santé Et de la Recherche Médicale, France |
| Condition | Celiac Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2020-02-27 |
| Primary Completion | 2030-02-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2020-02-27 with a primary completion date of 2030-02-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study focuses the mechanisms underlying the loss of intestinal homeostasis in celiac disease, refractory celiac disease and other immune diseases such as monogenic enteropathy, inflammatory bowel diseases or drug induced intestinal diseases. Mechanisms of transformation of lymphocytes leading to onset of lymphomatous complications of immune enteropathies will be investigated. Mechanisms of loss of hepatic lymphocytic homeostasis will also be assessed in liver associated diseases.
Eligibility Criteria
Inclusion Criteria: * 18 years or over * affiliated to social insurance * signed informed consent Exclusion Criteria: * pregnancy * under guardianship * not able to sign informed consent
Contact & Investigator
Georgia MALAMUT, MD, PhD
PRINCIPAL INVESTIGATOR
APHP, Université de Paris (Université Paris Descartes)
Frequently Asked Questions
Who can join the NCT04280510 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Celiac Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04280510 currently recruiting?
Yes, NCT04280510 is actively recruiting participants. Contact the research team at georgia.malamut@aphp.fr for enrollment information.
Where is the NCT04280510 trial being conducted?
This trial is being conducted at Créteil, France, Le Kremlin-Bicêtre, France, Paris, France, Paris, France.
Who is sponsoring the NCT04280510 clinical trial?
NCT04280510 is sponsored by Institut National de la Santé Et de la Recherche Médicale, France. The principal investigator is Georgia MALAMUT, MD, PhD at APHP, Université de Paris (Université Paris Descartes). The trial plans to enroll 200 participants.